HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under Lenalidomide Treatment Confirms the Suitability of Lenalidomide for Combination With T-Cell-Based Immunotherapy
OncoImmunology - United States
doi 10.1080/2162402x.2017.1316438
Full Text
Open PDFAbstract
Available in full text
Date
February 14, 2018
Authors
Publisher
Informa UK Limited